Disruption of MBD5 contributes to a spectrum of psychopathology and neurodevelopmental abnormalities

Molecular Psychiatry

Volumn 19, Issue 3, 2014, Pages 368-379

  Hodge, J C ^a   Mitchell, E ^a   Pillalamarri, V ^b   Toler, T L ^b   Bartel, F ^c   Kearney, H M ^d   Zou, Y S ^e   Tan, W H ^f,g   Hanscom, C ^b   Kirmani, S ^a   Hanson, R R ^h   Skinner, S A ^c   Rogers, R C ^c   Everman, D B ^c   Boyd, E ^d   Tapp, C ⁱ   Mullegama, S V ^j   Keelean Fuller, D ^k   Powell, C M ^k   Elsea, S H ^j   Morton, C C ^g,l,m   Gusella, J F ^b,g,m   Dupont, B ^c   Chaubey, A ^c   Lin, A E ^b   Talkowski, M E ^b,g,m   more..

^a MAYO CLINIC   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c GREENWOOD GENETIC CENTER   (United States)

^d Fullerton Genetics Center   (United States)

^e Pathology Associates Medical Laboratories   (United States)

^f BOSTON CHILDREN S HOSPITAL   (United States)

^g HARVARD MEDICAL SCHOOL   (United States)

^h MAYO GRADUATE SCHOOL   (United States)

ⁱ Agnesian Health Care   (United States)

^j VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^k UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^l BRIGHAM AND WOMEN S HOSPITAL   (United States)

^m BROAD INSTITUTE OF MIT AND HARVARD   (United States)

more..

Author keywords

2q23.1 microdeletion syndrome; Chromosomal microarray; MBD5; Next generation sequencing; regression

Indexed keywords

ANXIETY; BIPOLAR DISORDER; DEVELOPMENTAL DISABILITIES; DNA-BINDING PROTEINS; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MUTATION;

5' UNTRANSLATED REGION; ADOLESCENT; ADULT; ANXIETY DISORDER; ARTICLE; BIPOLAR DISORDER; CHILD; CLINICAL ARTICLE; EXON; FEMALE; GENE; GENE DELETION; GENE DISRUPTION; GENE LOCUS; GENE REARRANGEMENT; GENE SEQUENCE; GENE TRANSLOCATION; GENOME; HUMAN; LIFESPAN; MALE; MENTAL DISEASE; METHYL CPG BINDING DOMAIN PROTEIN 5 GENE; PHENOTYPE; POINT MUTATION;

EID: 84894590822     PISSN: 13594184     EISSN: 14765578     Source Type: Journal    
DOI: 10.1038/mp.2013.42     Document Type: Article

References (60)

1. Weiss LA, Shen Y, Korn JM, Arking DE, Miller DT, Fossdal R et al. Association between microdeletion and microduplication at 16p11.2 and autism. N Engl J Med 2008; 358: 667-675
2. Jacquemont S, Reymond A, Zufferey F, Harewood L, Walters RG, Kutalik Z et al. Mirror extreme BMI phenotypes associated with gene dosage at the chqromosome 16p11.2 locus. Nature 2011; 478: 97-102
3. Rosenfeld JA, Ballif BC, Lucas A, Spence EJ, Powell C, Aylsworth AS et al. Small deletions of SATB2 cause some of the clinical features of the 2q33.1 microdeletion syndrome. PLoS ONE 2009; 4: E6568
4. Talkowski ME, Rosenfeld JA, Blumenthal I, Pillalamarri V, Chiang C, Heilbut A et al. Sequencing chromosomal abnormalities reveals neurodevelopmental loci that confer risk across diagnostic boundaries. Cell 2012; 149: 525-537
5. Kleefstra T, Kramer JM, Neveling K, Willemsen MH, Koemans TS, Vissers LE et al. Disruption of an EHMT1-Associated chromatin-modification module causes intellectual disability. Am J Hum Genet 2012; 91: 1-10
6. Talkowski ME, Mullegama SV, Rosenfeld JA, van Bon BW, Shen Y, Repnikova EA et al. Assessment of 2q23.1 microdeletion syndrome implicates MBD5 as a single causal locus of intellectual disability, epilepsy, and autism spectrum disorder. Am J Hum Genet 2011; 89: 551-563
7. Williams SR, Mullegama SV, Rosenfeld JA, Dagli AI, Hatchwell E, Allen WP et al. Haploinsufficiency of MBD5 associated with a syndrome involving microcephaly, intellectual disabilities, severe speech impairment, and seizures. Eur J Hum Genet 2010; 18: 436-441
8. van Bon BW, Koolen DA, Brueton L, McMullan D, Lichtenbelt KD, Ades LC et al. The 2q23.1 microdeletion syndrome: Clinical and behavioural phenotype. Eur J Hum Genet 2010; 18: 163-170
9. Chung BH, Stavropoulos J, Marshall CR, Weksberg R, Scherer SW, Yoon G. 2q23 de novo microdeletion involving the MBD5 gene in a patient with developmental delay, postnatal microcephaly and distinct facial features. Am J Med Genet A 2011; 155A: 424-429
10. Jaillard S, Dubourg C, Gerard-Blanluet M, Delahaye A, Pasquier L, Dupont C et al. 2q23.1 Microdeletion identified by array comparative genomic hybridisation: An emerging phenotype with Angelman-like features? J Med Genet 2009; 46: 847-855
11. De Gregori M, Ciccone R, Magini P, Pramparo T, Gimelli S, Messa J et al. Cryptic deletions are a common finding in 'balanced' reciprocal and complex chromosome rearrangements: A study of 59 patients. J Med Genet 2007; 44: 750-762
12. Vissers LE, de Vries BB, Osoegawa K, Janssen IM, Feuth T, Choy CO et al. Array-based comparative genomic hybridization for the genomewide detection of submicroscopic chromosomal abnormalities. Am J Hum Genet 2003; 73: 1261-1270
13. Wagenstaller J, Spranger S, Lorenz-Depiereux B, Kazmierczak B, Nathrath M, Wahl D et al. Copy-number variations measured by single- nucleotidepolymorphism oligonucleotide arrays in patients with mental retardation. Am J Hum Genet 2007; 81: 768-779
14. Koolen DA, Vissers LE, Nillesen W, Smeets D, van Ravenswaaij CM, Sistermans EA et al. A novel microdeletion, del(2)(q22.3q23.3) in a mentally retarded patient, detected by array-based comparative genomic hybridization. Clin Genet 2004; 65: 429-432
15. deVries BB, Pfundt R, Leisink M, Koolen DA, Vissers LE, Janssen IM et al. Diagnostic genome profiling in mental retardation. Am J Hum Genet 2005; 77: 606-616
16. Chung BH, Mullegama S, Marshall CR, Lionel AC, Weksberg R, Dupuis L et al. Severe intellectual disability and autistic features associated with microduplication 2q23.1. Eur J Hum Genet 2011; 20: 398-403
17. Pinto D, Pagnamenta AT, Klei L, Anney R, Merico D, Regan R et al. Functional impact of global rare copy number variation in autism spectrum disorders. Nature 2010; 466: 368-372
18. Laget S, Joulie M, Le Masson F, Sasai N, Christians E, Pradhan S et al. The human proteins MBD5 and MBD6 associate with heterochromatin but they do not bind methylated DNA. PLoS ONE 2010; 5: E11982
19. Bogdanovic O, Veenstra GJ. DNA methylation and methyl-CpG binding proteins: Developmental requirements and function. Chromosoma 2009; 118: 549-565
20. Tennessen JA, Bigham AW, O'Connor TD, Fu W, Kenny EE, Gravel S et al. Evolution and functional impact of rare coding variation from deep sequencing of human exomes. Science 2012; 337: 64-69
21. Motobayashi M, Nishimura-Tadaki A, Inaba Y, Kosho T, Miyatake S, Niimi T et al. Neurodevelopmental features in 2q23.1 microdeletion syndrome: Report of a new patient with intractable seizures and review of literature. Am J Med Genet A 2012; 158A: 861-868
22. Noh GJ, Graham Jr. JM. 2q23.1 microdeletion of the MBD5 gene in a female with seizures, developmental delay and distinct dysmorphic features. Eur J Med Genet 2012; 55: 59-62
23. O'Roak BJ, Vives L, Girirajan S, Karakoc E, Krumm N, Coe BP et al. Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations. Nature 2012; 485: 246-250
24. Chiang C, Jacobsen JC, Ernst C, Hanscom C, Heilbut A, Blumenthal I et al. Complex reorganization and predominant non-homologous repair following chromosomal breakage in karyotypically balanced germline rearrangements and transgenic integration. Nat Genet 2012; 44: 390-397S391
25. Talkowski ME, Ernst C, Heilbut A, Chiang C, Hanscom C, Lindgren A et al. Nextgeneration sequencing strategies enable routine detection of balanced chromosome rearrangements for clinical diagnostics and genetic research. Am J Hum Genet 2011; 88: 469-481
26. Li H, Durbin R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 2009; 25: 1754-1760
27. Zweier C, Sticht H, Aydin-Yaylagul I, Campbell CE, Rauch A. Human TBX1 missense mutations cause gain of function resulting in the same phenotype as 22q11.2 deletions. Am J Hum Genet 2007; 80: 510-517
28. Yagi H, Furutani Y, Hamada H, Sasaki T, Asakawa S, Minoshima S et al. Role of TBX1 in human del22q11.2 syndrome. Lancet 2003; 362: 1366-1373
29. Verhagen JM, Diderich KE, Oudesluijs G, Mancini GM, Eggink AJ, Verkleij-Hagoort AC et al. Phenotypic variability of atypical 22q11.2 deletions not including TBX1 Am J Med Genet A 2012; 158A: 2412-2420
30. Girirajan S, Rosenfeld JA, Coe BP, Parikh S, Friedman N, Goldstein A et al. Phenotypic heterogeneity of genomic disorders and rare copy-number variants. N Engl J Med 2012; 367: 1321-1331
31. Miller DT, Adam MP, Aradhya S, Biesecker LG, Brothman AR, Carter NP et al. Consensus statement: Chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies. Am J Hum Genet 2010; 86: 749-764
32. Manning M, Hudgins L. Use of array-based technology in the practice of medical genetics. Genet Med 2007; 9: 650-653
33. Chen RM, Lupski JR, Greenberg F, Lewis RA. Ophthalmic manifestations of Smith-Magenis syndrome. Ophthalmology 1996; 103: 1084-1091
34. Greenberg F, Lewis RA, Potocki L, Glaze D, Parke J, Killian J et al. Multi-disciplinary clinical study of Smith-Magenis syndrome (deletion 17p11.2). Am J Med Genet 1996; 62: 247-254
35. Gropman AL, Duncan WC, Smith AC. Neurologic and developmental features of the Smith-Magenis syndrome (del 17p11.2). Pediatr Neurol 2006; 34: 337-350
36. Edelman EA, Girirajan S, Finucane B, Patel PI, Lupski JR, Smith AC et al. Gender, genotype, and phenotype differences in Smith-Magenis syndrome: A meta-Analysis of 105 cases. Clin Genet 2007; 71: 540-550
37. Smith AC, Dykens E, Greenberg F. Sleep disturbance in Smith-Magenis syndrome (del 17 p11.2). Am J Med Genet 1998; 81: 186-191
38. Martin SC, Wolters PL, Smith AC. Adaptive and maladaptive behavior in children with Smith-Magenis Syndrome. J Autism Dev Disord 2006; 36: 541-552
39. Gunay-Aygun M, Schwartz S, Heeger S, O'Riordan MA, Cassidy SB. The changing purpose of Prader-Willi syndrome clinical diagnostic criteria and proposed revised criteria. Pediatrics 2001; 108: E92
40. Jin DK. Systematic review of the clinical and genetic aspects of Prader-Willi syndrome. Korean J Pediatr 2011; 54: 55-63
41. Sinnema M, Maaskant MA, van Schrojenstein Lantman-de Valk HM, van Nieuwpoort IC, Drent ML, Curfs LM et al. Physical health problems in adults with Prader-Willi syndrome. Am J Med Genet A 2011; 155A: 2112-2124
42. Vaiani E, Herzovich V, Chaler E, Chertkoff L, Rivarola MA, Torrado M et al. Thyroid axis dysfunction in patients with Prader-Willi syndrome during the first 2 years of life. Clin Endocrinol (Oxf) 2010; 73: 546-550
43. West LA, Ballock RT. High incidence of hip dysplasia but not slipped capital femoral epiphysis in patients with Prader-Willi syndrome. J Pediatr Orthop 2004; 24: 565-567
44. Hered RW, Rogers S, Zang YF, Biglan AW. Ophthalmologic features of Prader-Willi syndrome. J Pediatr Ophthalmol Strab 1988; 25: 145-150
45. Williams CA, Driscoll DJ, Dagli AI. Clinical and genetic aspects of Angelman syndrome. Genet Med 2012; 12: 385-395
46. Michieletto P, Bonanni P, Pensiero S. Ophthalmic findings in Angelman syndrome. J Aapos 2011; 15: 158-161
47. Jackson L, Kline AD, Barr MA, Koch S. de Lange syndrome: A clinical review of 310 individuals. Am J Med Genet 1993; 47: 940-946
48. Kline AD, Krantz ID, Sommer A, Kliewer M, Jackson LG, FitzPatrick DR et al. Cornelia de Lange syndrome: Clinical review, diagnostic and scoring systems, and anticipatory guidance. Am J Med Genet A 2007; 143A: 1287-1296
49. Levin AV, Seidman DJ, Nelson LB, Jackson LG. Ophthalmologic findings in the Cornelia de Lange syndrome. J Pediatr Ophthalmol Strab 1990; 27: 94-102
50. Wygnanski-Jaffe T, Shin J, Perruzza E, Abdolell M, Jackson LG, Levin AV. Ophthalmologic findings in the Cornelia de Lange Syndrome. J Aapos 2005; 9: 407-415
51. Neul JL, Kaufmann WE, Glaze DG, Christodoulou J, Clarke AJ, Bahi-Buisson N et al. Rett syndrome: Revised diagnostic criteria and nomenclature. Ann Neurol 2010; 68: 944-950
52. Percy AK, Lane JB. Rett syndrome: Model of neurodevelopmental disorders. J Child Neurol 2005; 20: 718-721
53. Smeets EE, Pelc K, Dan B. Rett syndrome. Mol Syndromol 2012; 2: 113-127
54. Kleefstra T, van Zelst-Stams WA, Nillesen WM, Cormier-Daire V, Houge G, Foulds N et al. Further clinical and molecular delineation of the 9q subtelomeric deletion syndrome supports a major contribution of EHMT1 haploinsufficiency to the core phenotype. J Med Genet 2009; 46: 598-606
55. Stewart DR, Kleefstra T. The chromosome 9q subtelomere deletion syndrome. Am J Med Genet C 2007; 145C: 383-392
56. Willemsen MH, Vulto-van Silfhout AT, Nillesen WM, Wissink-Lindhout WM, van Bokhoven H, Philip N et al. Update on Kleefstra syndrome. Mol Syndromol 2012; 2: 202-212
57. Marangi G, Ricciardi S, Orteschi D, Lattante S, Murdolo M, Dallapiccola B et al. The Pitt-Hopkins syndrome: Report of 16 new patients and clinical diagnostic criteria. Am J Med Genet A 2011; 155A: 1536-1545
58. Peippo M, Ignatius J. Pitt-Hopkins syndrome. Mol Syndromol 2012; 2: 171-180
59. Van Balkom IDC, Vuijk PJ, Franssens M, Hoek HW, Hennekam RC. Development, cognition, and behaviour in Pitt-Hopkins syndrome. Dev Med Child Neurol 2012; 54: 925-931
60. Curry CJ, Stevenson RE, Aughton D, Byrne J, Carey JC, Cassidy S et al. Evaluation of mental retardation: Recommendations of a Consensus Conference: American College of Medical Genetics. Am J Med Genet 1997; 72: 468-477.